Comprehensive Management of High Risk Cardiovascular Patients

個数:

Comprehensive Management of High Risk Cardiovascular Patients

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 796 p.
  • 言語 ENG
  • 商品コード 9780849340666
  • DDC分類 616.1

Full Description

Filling a large gap in the literature, this book focuses on the management of patients who have, or are at risk of developing, cardiovascular disease. Designed to serve as a resource for the busy, practicing clinician, the approach is evidence-based but practical. Conceptual development and the exploration of biochemical and physiological mechanisms are balanced by focused attention on the everyday issues of caring for patients with specific metabolic and cardiovascular disorders.

Reinforced by case studies, the book discusses standards of care and challenging management issues. The authors discuss pharmacotherapeutic choices in light of findings from clinical trials, elements of care unique to women and people of different racial and ethnic groups, lifestyle modifications, and the risks and benefits of specific therapies. The book reviews comprehensive care in both primary and secondary prevention settings.

Moreover, Comprehensive Management of High Risk Cardiovascular Patients encourages primary care providers to get more involved in treating such disorders as atherosclerotic disease, congestive heart failure, severe hypertension, complex dyslipidemias, and chronic renal disease, among others.

Contents

Risk Factors for Cardiovascular Disease and the Framingham Study Equation, Arterial Hypertension, Obesity and Lifestyle Modification, Effects of Nutrient Supplements and Nutraceuticals on Risk for Cardiovascular Disease, Type 1 Diabetes Mellitus, Type 2 Diabetes, Management of Elevated Low-Density Lipoprotein Cholesterol. High-Density Lipoprotein Cholesterol, Triglycerides and Risk for Atherosclerotic Disease, Safety of Dyslipidemic Agents, The Metabolic Syndrome: Identification and Management of the Patient at High Risk for Cardiovascular Disease, Inflammatory Mediators and C-Reactive Protein, Chronic Kidney Disease, Anticoagulation and Antiplatelet Agents, Congestive Heart Failure: Epidemiology, Pathophysiology, and Current Therapies, Stroke Prevention, Peripheral Arterial Disease, Acute Myocardial Infarction, Tobacco and Cardiovascular Disease, Women and Coronary Heart Disease, Cardiovascular Disease in Racial and Ethnic Minorities

最近チェックした商品